MMA Media Download PDF
  • 326
  • 27
BioSpectrum Asia July 2020
Firms racing to develop antibody treatment for COVID-19

The Coronavirus COVID-19 has raged the world and has infected 8,993,659 cases and killed 469,587 (as of
June 23, 2020. Source World Health Organization (WHO)). Pharma firms, scientists and governments all over
the world are racing to find a cure for the virus. The entire world is waiting for the vaccine; Moderna’s mRNA
vaccine will begin phase III study in July. Amidst all this, some biopharma companies are pushing to develop
antibody based treatments for the virus. Does that have any merit? Why are firms putting billions of dollars
into it when vaccines are the ultimate solution? Let’s find out.
View Text Version Category : 26
  • Follow
  • 0
  • Embed
  • Share
  • Upload
Related publications